Wednesday 13 December 2017
Contact US    |    Archive
finanzen
3 months ago

XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today its agreement with Cedars-Sinai Medical Center located in Los Angeles, California, whereby XBiotech will provide its interleukin-1 alpha antagonist, MABp1, for a Phase I single...

Read on the original site


Ölpreise legen zu

- finanzen

e5-Team-Ausflug

- vienna

DGAP-News: 4SC AG

- finanzen
Hashtags:   

XBiotech

 | 

Announces

 | 

Agreement

 | 

with

 | 

Cedars

 | 

Sinai

 | 

Medical

 | 

Center

 | 

Evaluate

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
Österreich